Tanning beds and sun lamps provide the ultimate in relaxation and beauty! No more worries about the weather, how crowded the beach is, and if you've got enough time to soak up those rays. You can get that perfect tan when ever it's convenient for you, morning, noon, or night. Now you can enjoy the health benefits and the look good too!

With a tanning bed you can have that luxurious golden tan all year round, and fit it into your schedule with no problem. No more worries about over exposure, or dangerous UVB rays. It's a great way to supply your body with the essential vitamin D needed to keep you healthy.

There are plenty of bed choices on the market. Most salons offer top of the line beds, to keep you looking gorgeous. There are vertical beds, beds with additional tanning power if you're ready for that pro tan, beds with extra face lamps, and even beds with built in cooling systems.

It's simple, 10 to 20 relaxing minutes, a few times a week, will have you looking like you've just returned from a tropical island! So relax, get healthy, and enjoy that golden bronze tan that will make your friends green with envy!

As we get older our skin produces less of the natural oil that helps it retain its moisture. There are many contributing factors that can dry our skin. For example, excessive bathing in hot water, or very dry air can cause your skin to become dry. Dry skin can be prevented. The key is to seal moisture into the skin.

For women, their skin is one of their most treasured assets. Poor skin can send a woman into a complete frenzy. Women understand that their skin is the very first thing others see and notice, making a first impression of you before you ever speak.

Many women fight to find a good skin care program. Misinformation often leads us down the wrong path. We struggle to combat one problem and often create another.

Most important is the nutrients our skin receives. Like the rest of our body our skin requires vitamins and minerals to stay healthy. To ensure your skin is getting the right nutrients and the rest of your body too, follow the recommended food intake guideline, and take a multi vitamin daily.

The loofah sponges have become very popular in the past few years. And yes they are wonderful at removing dead skin. The problem is it also removes the natural oils from your skin. Without these oils you become dry and flaky because your body is unable to naturally lubricate new skin layers. This is where we get into a vicious circle ? we use the loofah more to remove flaking skin then we flake more. My recommendation is to not use your loofah more than twice a week and to then apply moisturizer directly to your damp skin.

Water in itself is drying to the skin. It is best to avoid really hot showers, use a moisturizing cleanser and stay away from harsh soaps. Pat dry and immediately apply a moisturizer to your body. The moister the skin, the better. Water is moisture, so trapping water between the moisturizer and the skin is good for the skin.

You can also use alpha-hydroxy products on your face. These products help remove dead dry skin and hydrate the new skin beneath. A word of caution ? Do not over use these products.

If you have cracked skin on your hands you need to limit the amount of water your hands are exposed to. The more water on your hands, the harder it will be for them to heal. Use heavy moisturizing hand creams to help seal the moisture into the skin.

Recent studies by Duke University show that Vitamin C promotes collagen growth. Collagen is responsible for giving skin its elasticity and keeping it smooth and wrinkle free. The more collagen in the skin, the younger it will look.

The drug-maker says it will undertake further study to establish which patients will benefit from the drug

US drug regulators have rescinded approval of a breast cancer drug, saying it is not effective enough to justify the risks of taking it.

The drug, Avastin, was approved for US use in 2008, but UK officials have also rejected claims that it prolongs life.

Further research showed it did not help patients live longer or improve quality of life, Food and Drug Administration commissioner Margaret Hamburg said.

Avastin will still be used to treat other kinds of cancer.

The drug is used to treat breast cancer that has spread to other parts of the body. It works by starving cancer cells of a blood supply.

However, its side-effects include severe high blood pressure, massive bleeding, heart attack or heart failure and tears in the stomach and intestines, FDA studies have found.

FDA approval of the drug had initially been given under a special programme that allows patients to start using promising treatments while the manufacturer finishes the studies to prove the medicine works as well as expected.

The decision to withdraw the approval - which can happen if results of the research do not match predictions - was not easy, the FDA said.

"With so much at stake, patients and their doctors count on the FDA to ensure the drugs they use have been shown to be safe and effective for their intended use. Sometimes, the results of rigorous testing can be disappointing," Ms Hamburg told the Associated Press news agency.

US health insurance companies could remove the drug, which can cost as much as $100,000 (£63,342) per year, from their coverage - although doctors would still be permitted to administer the drug.

But the government-backed Medicaid programme has said it has no immediate plans to change its policy of paying for it.

Some advocates of the drug disagree with the watchdog's decision.

"The bottom line is that they are throwing out the baby with the bathwater. There absolutely may be subsets of carefully chosen breast cancer patients who benefit from Avastin," said Dr Elisa Port, co-director of the Dubin Breast Center of Mount Sinai Hospital in New York.

Roche, the Swiss manufacturer of the drug, has said it will undertake further study of the treatment, especially with the chemotherapy drug paclitaxel, to try to identify which patients might be best suited to benefit from use of the drug.

The company says it expects the medicine will generate $7.6bn (£4.8m) of revenue annually, despite the FDA decision.

The drug was approved on the basis of a study that showed Avastin was able to stall the growth of breast cancer by five-and-a-half months, when used together with a standard chemotherapy treatment.

But subsequent studies revised the period of delay to between one and three months, and there was no evidence to show that the drug extended patients' lives.

The US decision comes after Avastin fell foul of health authorities in the UK and in Europe.

In February 2011, the UK's National Institute for Health and Clinical Excellence (NICE), the NHS drugs advisory body, said Avastin should not be used to treat secondary breast cancers.

NICE, which issues guidance for NHS in England and Wales, said there was insufficient evidence that the drug prolonged life.

This guidance followed a recommendation by the European Medicines Agency (EMA) that doctors only prescribe the drug in combination with the taxane drug, paclitaxel.